Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Anti-Infective Drugs Advisory Committee
March 6, 2006 Meeting
Jeffery S. Borer, M.D.
John Bradley, M.D.
James L. Omel, M.D. (posted 02/21/2006)
Steven Ebert, Pharm.D.
Jan Patterson, M.D.
February 23, 2006